Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis.

Cariolou M, Cupp MA, Evangelou E, Tzoulaki I, Berlanga-Taylor AJ.

BMJ Open. 2019 May 22;9(5):e027666. doi: 10.1136/bmjopen-2018-027666.

2.

Structural variants of Salmonella Typhimurium lipopolysaccharide induce less dimerization of TLR4/MD-2 and reduced pro-inflammatory cytokine production in human monocytes.

Aldapa-Vega G, Moreno-Eutimio MA, Berlanga-Taylor AJ, Jiménez-Uribe AP, Nieto-Velazquez G, López-Ortega O, Mancilla-Herrera I, Cortés-Malagón EM, Gunn JS, Isibasi A, Wong-Baeza I, López-Macías C, Pastelin-Palacios R.

Mol Immunol. 2019 Jul;111:43-52. doi: 10.1016/j.molimm.2019.03.003. Epub 2019 Apr 6.

3.

From Identification to Function: Current Strategies to Prioritise and Follow-Up GWAS Results.

Berlanga-Taylor AJ.

Methods Mol Biol. 2018;1793:259-275. doi: 10.1007/978-1-4939-7868-7_15. Review.

PMID:
29876901
4.

Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC.

EBioMedicine. 2018 May;31:133-142. doi: 10.1016/j.ebiom.2018.04.010. Epub 2018 Apr 10.

5.

Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease.

Gallone G, Haerty W, Disanto G, Ramagopalan SV, Ponting CP, Berlanga-Taylor AJ.

Hum Mol Genet. 2017 Jun 1;26(11):2164-2176. doi: 10.1093/hmg/ddx092.

6.

An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D.

Berlanga-Taylor AJ, Knight JC.

Mol Diagn Ther. 2014 Jun;18(3):261-72. doi: 10.1007/s40291-014-0087-2. Review.

7.

Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis.

Elangovan RI, Disanto G, Berlanga-Taylor AJ, Ramagopalan SV, Handunnetthi L.

J Hum Genet. 2014 Apr;59(4):211-5. doi: 10.1038/jhg.2014.3. Epub 2014 Feb 13.

PMID:
24522295
8.

CGAT: computational genomics analysis toolkit.

Sims D, Ilott NE, Sansom SN, Sudbery IM, Johnson JS, Fawcett KA, Berlanga-Taylor AJ, Luna-Valero S, Ponting CP, Heger A.

Bioinformatics. 2014 May 1;30(9):1290-1. doi: 10.1093/bioinformatics/btt756. Epub 2014 Jan 5.

9.

DNase hypersensitive sites and association with multiple sclerosis.

Disanto G, Kjetil Sandve G, Ricigliano VA, Pakpoor J, Berlanga-Taylor AJ, Handel AE, Kuhle J, Holden L, Watson CT, Giovannoni G, Handunnetthi L, Ramagopalan SV.

Hum Mol Genet. 2014 Feb 15;23(4):942-8. doi: 10.1093/hmg/ddt489. Epub 2013 Oct 2.

PMID:
24092328
10.

Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease.

Handel AE, Sandve GK, Disanto G, Berlanga-Taylor AJ, Gallone G, Hanwell H, Drabløs F, Giovannoni G, Ebers GC, Ramagopalan SV.

BMC Med. 2013 Jul 12;11:163. doi: 10.1186/1741-7015-11-163.

11.

Vitamin D and multiple sclerosis: what is the clinical impact?

Berlanga-Taylor AJ, Ramagopalan SV.

Expert Opin Med Diagn. 2013 May;7(3):227-9. doi: 10.1517/17530059.2013.786040. Epub 2013 Apr 9.

PMID:
23565817
12.

Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.

Disanto G, Hall C, Lucas R, Ponsonby AL, Berlanga-Taylor AJ, Giovannoni G, Ramagopalan SV; Ausimmune Investigator Group.

Mult Scler. 2013 Sep;19(10):1355-8. doi: 10.1177/1352458513477231. Epub 2013 Feb 14.

PMID:
23413297
13.

Vitamin D receptor binding, chromatin states and association with multiple sclerosis.

Disanto G, Sandve GK, Berlanga-Taylor AJ, Ragnedda G, Morahan JM, Watson CT, Giovannoni G, Ebers GC, Ramagopalan SV.

Hum Mol Genet. 2012 Aug 15;21(16):3575-86. doi: 10.1093/hmg/dds189. Epub 2012 May 16.

14.

Re: "Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study".

Berlanga-Taylor AJ, Disanto G, Ramagopalan SV.

Am J Epidemiol. 2012 Apr 1;175(7):727-8; author reply 728-9. doi: 10.1093/aje/kwr442. Epub 2012 Mar 13. No abstract available.

PMID:
22415034
15.

Genomic regions associated with multiple sclerosis are active in B cells.

Disanto G, Sandve GK, Berlanga-Taylor AJ, Morahan JM, Dobson R, Giovannoni G, Ramagopalan SV.

PLoS One. 2012;7(3):e32281. doi: 10.1371/journal.pone.0032281. Epub 2012 Mar 2.

16.

Rare variants in the CYP27B1 gene are associated with multiple sclerosis.

Ramagopalan SV, Dyment DA, Cader MZ, Morrison KM, Disanto G, Morahan JM, Berlanga-Taylor AJ, Handel A, De Luca GC, Sadovnick AD, Lepage P, Montpetit A, Ebers GC.

Ann Neurol. 2011 Dec;70(6):881-6. doi: 10.1002/ana.22678.

PMID:
22190362
17.

Vitamin D-gene interactions in multiple sclerosis.

Berlanga-Taylor AJ, Disanto G, Ebers GC, Ramagopalan SV.

J Neurol Sci. 2011 Dec 15;311(1-2):32-6. doi: 10.1016/j.jns.2011.08.041. Epub 2011 Oct 13. Review.

PMID:
22000399

Supplemental Content

Loading ...
Support Center